Press conference, March 19th, Brussels, Belgium
The consortium led by Universitätsklinikum Erlangen and the European Stroke Research Network for Hypothermia (EuroHYP), is to announce the launch of a clinical trial of unprecedented scale which will be rolled out across 25 countries in Europe to assess mild hypothermia as the most promising treatment for ischemic stroke at a PRESS CONFERENCE on March 19, 2012 in Brussels, Belgium.
The key officers in the project will be outlining the final details of the EUROHYP-1 trial, and the result of the submission for funding by the European Commission under the Seventh Framework Programme
Journalists will have the opportunity to hear the latest on this promising project, and to find out the role each leading country will be taking in the research and ask questions also to the stroke researchers, patient groups and Small and Medium sized Enterprises involved in the trial, which will also be attending.
The EuroHYP-1 trial is a pan-European, open, randomised, phase III clinical trial which will assess the benefit of therapeutic cooling in adult patients with acute ischaemic stroke. In addition to efficacy and safety, the economic impact of therapeutic hypothermia will be also evaluated.
The EuroHYP consortium brings together leading European experts in statistical design and analysis, therapeutic hypothermia, imaging, health economics, ultrasound, biomarkers, and trial execution (implementation and monitoring) as well as European patient and family advocacy groups and Small and Medium-size Enterprises
The press conference will be followed by the opportunity to continue the discussion over a coffee and engage in one-to-one dialogue with experts, patient representatives and other stakeholders in the trial such as SMEs developing the new technologies and processes necessary for the trial, which is expected to lead to significant spin offs in term of technological innovation and R&D capabilities
Information will be available for the press in French, English, German, Spanish and Italian.
When: Monday March 19, 2012, 10:30am to 11:00am CET
Where: Press Club Brussels Europe, Rue Froissart 95, 1040 Brussels, Belgium
Further details available here
Archive Press Materials
Report of Press Coverage following Press Conference
In 2010 a consensus meeting hosted by EuroHYP agreed the Hypothermia: Call for Action, later published in the International Journal of Stroke
In this JCBFM Review Article> the EuroHYP investigators discuss the various considerations which have led to the design of the EuroHYP trial protocol
In one of the most highly cited systematic reviews of animal studies van der Worp and colleagues show that animal data supporting hypothermia is more convincing than for any other intervention